Skip to content
Menu

Intensity Therapeutics Q3 EPS $(1.09) Misses $(0.99) Estimate. Cash and Equivalents $8.5M

Benzinga Newsdesk 2 weeks ago

NewsEarningsEarnings Misses

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Intensity Therapeutics (NASDAQ:INTS) reported quarterly losses of $(1.09) per share which missed the analyst consensus estimate of $(0.99) by 10.1 percent. This is a 172.67 percent decrease over earnings of $1.50 per

Intensity Therapeutics (NASDAQ:INTS) reported quarterly losses of $(1.09) per share which missed the analyst consensus estimate of $(0.99) by 10.1 percent. This is a 172.67 percent decrease over earnings of $1.50 per share from the same period last year.

Read at benzinga.com